DGX - Quest Diagnostics Incorporated
| Previous Close | 105.72 |
| Open | 105.98 |
| Bid | 107.32 x 1000 |
| Ask | 107.34 x 1100 |
| Day's Range | 105.87 - 107.97 |
| 52 Week Range | 78.95 - 108.76 |
| Volume | 1,234,185 |
| Avg. Volume | 906,411 |
| Market Cap | 14.466B |
| Beta (3Y Monthly) | 0.84 |
| PE Ratio (TTM) | 20.26 |
| EPS (TTM) | 5.30 |
| Earnings Date | Oct 21, 2019 - Oct 25, 2019 |
| Forward Dividend & Yield | 2.12 (2.01%) |
| Ex-Dividend Date | 2019-10-03 |
| 1y Target Est | 108.19 |
- PR Newswire
National Business Group on Health Honors Quest Diagnostics with Best Employers: Excellence in Health & Well-Being Award
Quest Diagnostics Recognized for Offering One of the Nation's Best Workforce Health and Well-being Initiatives SECAUCUS, N.J. , Sept. 19, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's ...
- Zacks
DGX vs. ADUS: Which Stock Is the Better Value Option?
DGX vs. ADUS: Which Stock Is the Better Value Option?
- Zacks
Is Quest Diagnostics (DGX) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Simply Wall St.
What Should We Expect From Quest Diagnostics Incorporated's (NYSE:DGX) Earnings In The Year Ahead?
Looking at Quest Diagnostics Incorporated's (NYSE:DGX) earnings update in June 2019, analyst consensus outlook appear...
- PR Newswire
Quest Diagnostics and hc1 Collaborate to Optimize Enterprise-wide Laboratory Testing for Health Systems
Strategic collaboration aims to improve patient care and reduce costs across thousands of health systems nationwide by delivering insights that empower optimal lab testing SECAUCUS, N.J. and INDIANAPOLIS ...
- PR Newswire
Workforce Drug Positivity Increases in More Than One-Third of U.S. Industry Sectors Examined, According to Quest Diagnostics Multi-Year Analysis
SECAUCUS, N.J., Sept. 11, 2019 /PRNewswire/ -- One third of U.S. industry sectors experienced year-over-year double-digit increases in workforce drug positivity between 2015 and 2018, according to a new analysis of industry-specific data by Quest Diagnostics (DGX), the world's leading provider of diagnostic information services. The Quest Diagnostics Drug Testing Index™ industry analysis of general U.S. workforce urine drug test results shows year-over-year double-digit increases in workplace drug positivity in six of the 17 sectors reported.
- MarketWatch
A growing share of workers in these industries is failing drug tests — and public safety could be at risk
A higher percentage of people nationwide tested positive for a controlled substance in 2018 than in previous years.
- Zacks
Cybersecurity a Top Priority for Healthcare: 3 Stocks to Watch
As cybersecurity is the need of the hour for U.S. healthcare companies, let's keep an eye on three stocks.
- Zacks
All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy
Quest Diagnostics (DGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
- PR Newswire
Quest Diagnostics Names Manuel O. Méndez as New Commercial Leader
SECAUCUS, N.J. , Sept. 10, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that Manuel O. Méndez has been named Senior ...
- Simply Wall St.
Is It Too Late To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?
Let's talk about the popular Quest Diagnostics Incorporated (NYSE:DGX). The company's shares saw its share price hover...
- Zacks
Quest Diagnostics' New Acquisitions and Pacts Aid Growth
Quest Diagnostics' (DGX) nine deals concluded in 2018 strengthen its potential to fulfill its goals set for 2019.
- PR Newswire
Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference
SECAUCUS, N.J., Aug. 28, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York. Stephen Rusckowski, Chairman, President and CEO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.
- American City Business Journals
LabCorp joins in $17.5M round for Cambridge diagnostic startup Boston Microfluidics
Boston Microfluidics currently offers two tests for lipids and A1C levels, but CEO Brandon Johnson said the current tool could handle up to 13 tests and potentially more.
- PR Newswire
Quest Diagnostics to Speak at the Baird 2019 Global Healthcare Conference
SECAUCUS, N.J. , Aug. 23, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the ...
- Zacks
Why Is Quest Diagnostics (DGX) Down 0.2% Since Last Earnings Report?
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Barrons.com
Why a $4.9 Billion Fund Is Betting on Berkshire Hathaway, Dollar Tree, and Quest Diagnostics
The FMI Large Cap fund doesn’t flee into cash when it sees a bear market on the way. Instead, it buckles down on its value investing philosophy and a concentrated set of stock picks.
- Zacks
Should Value Investors Pick Quest Diagnostics (DGX) Stock?
Let's see if Quest Diagnostics (DGX) stock is a good choice for value-oriented investors right now from multiple angles.
- Zacks
Outlook for Outpatient and Home Healthcare Industry Looks Bright
Outlook for Outpatient and Home Healthcare Industry Looks Bright
- American City Business Journals
Frozen assets: How a startup wants to cryobank your cells to fight cancer in the future
The Florida startup has Bay Area investors and is aiming straight at people willing to pay thousands of dollars to beat cancer in the future.
- PR Newswire
Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J. , Aug. 15, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly ...
- GuruFocus.com
Chris Davis Buys 3 Stocks in 2nd Quarter
Guru’s largest new position is Humana Continue reading...
- Simply Wall St.
Can You Imagine How Quest Diagnostics's (NYSE:DGX) Shareholders Feel About The 62% Share Price Increase?
When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses...
Motley FoolOxford Immunotec Global PLC (OXFD) Q2 2019 Earnings Call Transcript
OXFD earnings call for the period ending June 30, 2019.
- Zacks
DGX vs. LHCG: Which Stock Is the Better Value Option?
DGX vs. LHCG: Which Stock Is the Better Value Option?
